Classifying responders and non-responders; does it help when there is evidence of differentially responding patient groups?

Journal of Psychiatric Research

Volumn 46, Issue 9, 2012, Pages 1169-1173

  Boessen, Ruud ^a   Groenwold, Rolf H H ^a   Knol, Mirjam J ^a   Grobbee, Diederick E ^a   Roes, Kit C B ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antidepressant clinical trials; Dichotomization; Outcome heterogeneity; Responder analyses

Indexed keywords

AMITRIPTYLINE; MIRTAZAPINE; PLACEBO;

ARTICLE; BIMODALITY; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; NORMAL DISTRIBUTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SAMPLE SIZE; SIMULATION; STATISTICAL DISTRIBUTION; STUDENT T TEST; TREATMENT RESPONSE;

EID: 84864381159     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2012.05.005     Document Type: Article

References (16)

1. Altman D.G., Royston P. The cost of dichotomising continuous variables. British Medical Journal 2006, 332:1080.
2. Cipriani A., Furukawa T.A., Salanti G., Geddes J.R., Higgins J.P., Churchill R., et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009, 373:746-758.
3. Cohen J. The cost of dichotomization. Applied Psychological Measurement 1983, 3:249-253.
4. Decoster J., Iselin A.M., Gallucci M. A conceptual and empirical examination of justifications for dichotomization. Psychological Methods 2009, 14:349-366.
5. Fava M. Diagnosis and definition of treatment-resistant depression. Biological Psychiatry 2003, 53(8):649-659.
6. Fava M., Davidson K.G. Definition and epidemiology of treatment-resistant depression. Psychiatric Clinics of North America 1996, 19(2):179-200.
7. Fedorov V., Mannino F., Zhang R. Consequences of dichotomization. Pharmaceutical Statistics 2009, 8:50-61.
8. Keitner G.I., Ryan C.E., Miller I.W., Kohn R., Epstein N.B. 12-month outcome of patients with major depression and comorbid psychiatric or medical illness (compound depression). American Journal of Psychiatry 1991, 148:345-350.
9. Kornstein S.G., Schneider R.K. Clinical features of treatment-resistant depression. Journal of Clinical Psychiatry 2001, 62(Suppl. 6):18-25.
10. MacCallum R.C., Zhang S., Preacher K.J., Rucker D.D. On the practice of dichotomization of quantitative variables. Psychological Methods 2002, 7:19-40.
11. Molenberghs G., Thijs H., Jansen I., Beunckens C., Kenward M.G., Mallinckrodt C., et al. Analyzing incomplete longitudinal clinical trial data. Biostatistics 2004, 5:445-464.
12. Naggara O., Raymond J., Guilbert F., Roy D., Weill A., Altman D.G. Analysis by categorizing or dichotomizing continuous variables is inadvisable: an example from the natural history of unruptured aneurysms. American Journal of Neuroradiology 2011, 32:437-440.
13. Ragland D.R. Dichotomizing continuous outcome variables: dependence of the magnitude of association and statistical power on the cutpoint. Epidemiology 1992, 3:434-440.
14. Royston P., Altman D.G., Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Statistics in Medicine 2006, 25(1):127-141.
15. Senn S. Disappointing dichotomies. Pharmaceutical Statistics 2003, 4:239-240.
16. Souery D., Amsterdam J., de Montigny C., Lecrubier Y., Montgomery S., Lipp O., et al. Treatment resistant depression: methodological overview and operational criteria. European Neuropsychopharmacology 1999, 9(1-2):83-91.